-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.00328.57% Upside
Virpax Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Virpax Pharmaceuticals, Inc.?
Virpax Pharmaceuticals, Inc. has been rated by research analysts at Maxim Group in the past 90 days.